Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Knöbl

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 30, 2006
Unraveling the immunologic response in thrombotic thrombocytopenic purpuraP Knöbl
Journal of Thrombosis and Haemostasis : JTH|March 17, 2015
NET untangled in TMA?P Knöbl
Wiener Medizinische Wochenschrift (1946)|January 1, 2003
[Pathophysiology and therapy of sepsis-associated coagulation disorders]P Knöbl
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 4, 2016
[Thrombocytopenia in the intensive care unit : Diagnosis, differential diagnosis, and treatment]P Knöbl
Bailliere'S Clinical Haematology|March 31, 1999
Acquired factor V inhibitorsP Knöbl, K Lechner
Vox Sanguinis|October 26, 1999
Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IXP Knöbl, K Derfler
Archives of Pathology & Laboratory Medicine|June 1, 1997
Automated five-part white blood cell differential counts. Efficiency of software-generated white blood cell suspect flags of the hematology analyzers Sysmex SE-9000, Sysmex NE-8000, and Coulter STKSR Thalhammer-Scherrer, P Knöbl, L Korninger, et al.
Wiener Klinische Wochenschrift|January 1, 1994
Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular diseaseP Knöbl, P Pietschmann, C Schnack, et al.
Thrombosis and Haemostasis|February 1, 1996
Probability of recurrence of thrombosis in patients with and without factor V LeidenC Rintelen, I Pabinger, P Knöbl, et al.
Annals of Hematology|July 28, 1999
The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusionsP Stohlawetz, G Stiegler, P Knöbl, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|August 30, 2006
Unraveling the immunologic response in thrombotic thrombocytopenic purpuraP Knöbl
Journal of Thrombosis and Haemostasis : JTH|March 17, 2015
NET untangled in TMA?P Knöbl
Wiener Medizinische Wochenschrift (1946)|January 1, 2003
[Pathophysiology and therapy of sepsis-associated coagulation disorders]P Knöbl
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 4, 2016
[Thrombocytopenia in the intensive care unit : Diagnosis, differential diagnosis, and treatment]P Knöbl
Bailliere'S Clinical Haematology|March 31, 1999
Acquired factor V inhibitorsP Knöbl, K Lechner
Vox Sanguinis|October 26, 1999
Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IXP Knöbl, K Derfler
Archives of Pathology & Laboratory Medicine|June 1, 1997
Automated five-part white blood cell differential counts. Efficiency of software-generated white blood cell suspect flags of the hematology analyzers Sysmex SE-9000, Sysmex NE-8000, and Coulter STKSR Thalhammer-Scherrer, P Knöbl, L Korninger, et al.
Wiener Klinische Wochenschrift|January 1, 1994
Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular diseaseP Knöbl, P Pietschmann, C Schnack, et al.
Thrombosis and Haemostasis|February 1, 1996
Probability of recurrence of thrombosis in patients with and without factor V LeidenC Rintelen, I Pabinger, P Knöbl, et al.
Annals of Hematology|July 28, 1999
The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusionsP Stohlawetz, G Stiegler, P Knöbl, et al.
Pageof 8